DEVELOPMENT AND CHARACTERIZATION OF BILAYER SUSTAINED RELEASE TABLETS OF TRAMADOL HCL AND ACETAMINOPHEN

http://dx.doi.org/10.31703/gpsr.2016(I-I).02      10.31703/gpsr.2016(I-I).02      Published : Dec 2016
Authored by : Rashid Javed , Sana Ijaz , Kainat Waqar , Muhammad Imran Khan

02 Pages : 6-16

References

  • Abdullah, E., & Geldart, D. (1999). The use of bulk density measurements as flowability indicators. Powder technology, 102(2), 151-165
  • Albhar, K. G., Wagh, V. S., & Chavan, B. (2012). Effect of HPMC K4M, HPMC K15M, sodium alginate and carbopol 934 in the formulation of carbonyl iron capsule. J Der Pharm Lett, 4(1), 94-367.
  • Asane, G., Nirmal, S., Rasal, K., Naik, A., Mahadik, M., & Rao, Y. M. (2008). Polymers for mucoadhesive drug delivery system: a current status. Drug Development and Industrial Pharmacy, 34(11), 1246-1266.
  • Atram, S., Udavant, Y., Salunke, R., Neb, G., Shahi, S., Gulecha, B., & Padalkar, A. (2009). Formulation of bilayer tablet containing metoprolol succinate and amlodipine besylate as a model drug for antihypertensive therapy. Journal of Pharmacy Research, 2(8), 1335- 1347.
  • Botting, R. M. (2000). Mechanism of action of acetaminophen: is there a cyclooxygenase 3? Clinical Infectious Diseases, 31(Supplement_5), S202-S210.
  • Brayfield, A. (2014). Tramadol hydrochloride. Martindale: The Complete Drug Reference. Pharmaceutical Press., 5.
  • Cossmann, M., & Wilsmann, K. (1987). Effect and side effects of tramadol: an open phase IV study with 7198 patients. Therapiewoche, 37, 3475- 3485.
  • Dudhat, K. R. (2013). Design and Development of Bilayer Tablets of Ondansetron Hydrochloride and Pantoprazole Sodium for Targeted Drug Delivery.
  • Dunnett, C., & Crisafio, R. (1955). The operating characteristics of some official weight variation tests for tablets. Journal of Pharmacy and Pharmacology, 7(1), 314-327.
  • Frizon, F., de Oliveira Eloy, J., Donaduzzi, C. M., Mitsui, M. L., & Marchetti, J. M. (2013). Dissolution rate enhancement of loratadine in polyvinylpyrrolidone K-30 solid dispersions by solvent methods. Powder technology, 235, 532-539.
  • Gopinath, C., Bindu, V. H., & Nischala, M. (2013). An overview on bilayered tablet technology. Journal of global trends in pharmaceutical sciences, 4(2), 1077-1085.
  • Henry, B. R. (1961). Friable tablet and process for manufacturing same. In: Google Patents.
  • Hlinak, A. J., Kuriyan, K., Morris, K. R., Reklaitis, G. V., & Basu, P. K. (2006). Understanding critical material properties for solid dosage form design. Journal of Pharmaceutical Innovation, 1(1), 12-17.
  • Jayaprakash, S., Halith, S. M., Pillai, K. K., Balasubramaniyam, P., Firthouse, P. M., & Boopathi, M. (2011). Formulation and evaluation of bilayer tablets of amlodipine besilate and metprolol succinate. Der Pharmacia Lettre, 3(4), 143-154.
  • Kadian, S. S., & Harikumar, S. (2016). Eudragit and its pharmaceutical significance. In
  • Kale, S. S., Saste, V. S., Ughade, P. L., & Baviskar, D. T. (2011). Bilayer tablet. International Journal of Pharmaceutical Sciences Review and Research, 9(1), 25-30.
  • Khanmohammadi, M., Garmarudi, A. B., Ghasemi, K., Jaliseh, H. K., & Kaviani, A. (2009). Diagnosis of colon cancer by attenuated total reflectance- fourier transform infrared microspectroscopy and soft independent modeling of class analogy. Medical Oncology, 26(3), 292-297.
  • KITAZAWA, S., JOHNO, I., ITO, Y., TERAMURA, S., & OKADA, J. (1975). Effects of hardness on the disintegration time and the dissolution rate of uncoated caffeine tablets. Journal of Pharmacy and Pharmacology, 27(10), 765-770.
  • Mohammed, M., Maringanti, P. S., & Mamidi, S. (2011). Formulation and evaluation of bilayered tablets of montelukast and levocetrizine dihydrochloride using natural and synthetic polymers. International Journal of drug delivery, 3(4), 597.
  • Mužíková, J., & Nováková, P. (2007). A study of the properties of compacts from silicified microcrystalline celluloses. Drug development and industrial pharmacy, 33(7), 775-781.
  • Narendra, C., Srinath, M., & Babu, G. (2006). Optimization of bilayer floating tablet containing metoprolol tartrate as a model drug for gastric retention. AAPS PharmSciTech, 7(2), E23-E29.
  • Nguyen, T. H., Morton, D., & Hapgood, K. (2015). Prediction of the tablet hardness: Exploration of microcrystalline cellulose and scale-up in wet granulation. Asia Pacific Confederation of Chemical Engineering Congress 2015: APCChE 2015, incorporating CHEMECA 2015,
  • Reddy, K. R., Mutalik, S., & Reddy, S. (2003). Once- daily sustained-release matrix tablets of nicorandil: formulation and in vitro evaluation. AAPS PharmSciTech, 4(4), 480-488.
  • Sánchez, L., Torrado, S., & Lastres, J. (1995). Gelatinized/freeze-dried starch as excipient in sustained release tablets. International journal of pharmaceutics, 115(2), 201-208.
  • Scott, L. J., & Perry, C. M. (2000). Tramadol. Drugs, 60(1), 139-176.
  • Shamma, R. N., & Basha, M. (2013). Soluplus®: A novel polymeric solubilizer for optimization of Carvedilol solid dispersions: Formulation design and effect of method of preparation. Powder technology, 237, 406-414.
  • Shiyani, B., Gattani, S., & Surana, S. (2008). Formulation and evaluation of bi-layer tablet of metoclopramide hydrochloride and ibuprofen. AAPS PharmSciTech, 9(3), 818-827.
  • Skowyra, J., Pietrzak, K., & Alhnan, M. A. (2015). Fabrication of extended-release patient-tailored prednisolone tablets via fused deposition modelling (FDM) 3D printing. European Journal of Pharmaceutical Sciences, 68, 11-17.
  • Stegner, W. (2000). Angle of repose. Penguin.
  • SWAIN, R. P., KUMARI, T. R., & PANDA, S. (2016). Formulation development and evaluation of sustained release ibuprofen tablets with acrylic polymers (Eudragit) and HPMC. International Journal of Pharmacy and Pharmaceutical Sciences, 8(2).
  • Ward, B., & Alexander-Williams, J. M. (1999). Paracetamol revisited: a review of the pharmacokinetics and pharmacodynamics. Acute Pain, 2(3), 139-149.
  • Weitzel, M. J. (2012). The estimation and use of measurement uncertainty for a drug substance test procedure validated according to USP

References

  • Abdullah, E., & Geldart, D. (1999). The use of bulk density measurements as flowability indicators. Powder technology, 102(2), 151-165
  • Albhar, K. G., Wagh, V. S., & Chavan, B. (2012). Effect of HPMC K4M, HPMC K15M, sodium alginate and carbopol 934 in the formulation of carbonyl iron capsule. J Der Pharm Lett, 4(1), 94-367.
  • Asane, G., Nirmal, S., Rasal, K., Naik, A., Mahadik, M., & Rao, Y. M. (2008). Polymers for mucoadhesive drug delivery system: a current status. Drug Development and Industrial Pharmacy, 34(11), 1246-1266.
  • Atram, S., Udavant, Y., Salunke, R., Neb, G., Shahi, S., Gulecha, B., & Padalkar, A. (2009). Formulation of bilayer tablet containing metoprolol succinate and amlodipine besylate as a model drug for antihypertensive therapy. Journal of Pharmacy Research, 2(8), 1335- 1347.
  • Botting, R. M. (2000). Mechanism of action of acetaminophen: is there a cyclooxygenase 3? Clinical Infectious Diseases, 31(Supplement_5), S202-S210.
  • Brayfield, A. (2014). Tramadol hydrochloride. Martindale: The Complete Drug Reference. Pharmaceutical Press., 5.
  • Cossmann, M., & Wilsmann, K. (1987). Effect and side effects of tramadol: an open phase IV study with 7198 patients. Therapiewoche, 37, 3475- 3485.
  • Dudhat, K. R. (2013). Design and Development of Bilayer Tablets of Ondansetron Hydrochloride and Pantoprazole Sodium for Targeted Drug Delivery.
  • Dunnett, C., & Crisafio, R. (1955). The operating characteristics of some official weight variation tests for tablets. Journal of Pharmacy and Pharmacology, 7(1), 314-327.
  • Frizon, F., de Oliveira Eloy, J., Donaduzzi, C. M., Mitsui, M. L., & Marchetti, J. M. (2013). Dissolution rate enhancement of loratadine in polyvinylpyrrolidone K-30 solid dispersions by solvent methods. Powder technology, 235, 532-539.
  • Gopinath, C., Bindu, V. H., & Nischala, M. (2013). An overview on bilayered tablet technology. Journal of global trends in pharmaceutical sciences, 4(2), 1077-1085.
  • Henry, B. R. (1961). Friable tablet and process for manufacturing same. In: Google Patents.
  • Hlinak, A. J., Kuriyan, K., Morris, K. R., Reklaitis, G. V., & Basu, P. K. (2006). Understanding critical material properties for solid dosage form design. Journal of Pharmaceutical Innovation, 1(1), 12-17.
  • Jayaprakash, S., Halith, S. M., Pillai, K. K., Balasubramaniyam, P., Firthouse, P. M., & Boopathi, M. (2011). Formulation and evaluation of bilayer tablets of amlodipine besilate and metprolol succinate. Der Pharmacia Lettre, 3(4), 143-154.
  • Kadian, S. S., & Harikumar, S. (2016). Eudragit and its pharmaceutical significance. In
  • Kale, S. S., Saste, V. S., Ughade, P. L., & Baviskar, D. T. (2011). Bilayer tablet. International Journal of Pharmaceutical Sciences Review and Research, 9(1), 25-30.
  • Khanmohammadi, M., Garmarudi, A. B., Ghasemi, K., Jaliseh, H. K., & Kaviani, A. (2009). Diagnosis of colon cancer by attenuated total reflectance- fourier transform infrared microspectroscopy and soft independent modeling of class analogy. Medical Oncology, 26(3), 292-297.
  • KITAZAWA, S., JOHNO, I., ITO, Y., TERAMURA, S., & OKADA, J. (1975). Effects of hardness on the disintegration time and the dissolution rate of uncoated caffeine tablets. Journal of Pharmacy and Pharmacology, 27(10), 765-770.
  • Mohammed, M., Maringanti, P. S., & Mamidi, S. (2011). Formulation and evaluation of bilayered tablets of montelukast and levocetrizine dihydrochloride using natural and synthetic polymers. International Journal of drug delivery, 3(4), 597.
  • Mužíková, J., & Nováková, P. (2007). A study of the properties of compacts from silicified microcrystalline celluloses. Drug development and industrial pharmacy, 33(7), 775-781.
  • Narendra, C., Srinath, M., & Babu, G. (2006). Optimization of bilayer floating tablet containing metoprolol tartrate as a model drug for gastric retention. AAPS PharmSciTech, 7(2), E23-E29.
  • Nguyen, T. H., Morton, D., & Hapgood, K. (2015). Prediction of the tablet hardness: Exploration of microcrystalline cellulose and scale-up in wet granulation. Asia Pacific Confederation of Chemical Engineering Congress 2015: APCChE 2015, incorporating CHEMECA 2015,
  • Reddy, K. R., Mutalik, S., & Reddy, S. (2003). Once- daily sustained-release matrix tablets of nicorandil: formulation and in vitro evaluation. AAPS PharmSciTech, 4(4), 480-488.
  • Sánchez, L., Torrado, S., & Lastres, J. (1995). Gelatinized/freeze-dried starch as excipient in sustained release tablets. International journal of pharmaceutics, 115(2), 201-208.
  • Scott, L. J., & Perry, C. M. (2000). Tramadol. Drugs, 60(1), 139-176.
  • Shamma, R. N., & Basha, M. (2013). Soluplus®: A novel polymeric solubilizer for optimization of Carvedilol solid dispersions: Formulation design and effect of method of preparation. Powder technology, 237, 406-414.
  • Shiyani, B., Gattani, S., & Surana, S. (2008). Formulation and evaluation of bi-layer tablet of metoclopramide hydrochloride and ibuprofen. AAPS PharmSciTech, 9(3), 818-827.
  • Skowyra, J., Pietrzak, K., & Alhnan, M. A. (2015). Fabrication of extended-release patient-tailored prednisolone tablets via fused deposition modelling (FDM) 3D printing. European Journal of Pharmaceutical Sciences, 68, 11-17.
  • Stegner, W. (2000). Angle of repose. Penguin.
  • SWAIN, R. P., KUMARI, T. R., & PANDA, S. (2016). Formulation development and evaluation of sustained release ibuprofen tablets with acrylic polymers (Eudragit) and HPMC. International Journal of Pharmacy and Pharmaceutical Sciences, 8(2).
  • Ward, B., & Alexander-Williams, J. M. (1999). Paracetamol revisited: a review of the pharmacokinetics and pharmacodynamics. Acute Pain, 2(3), 139-149.
  • Weitzel, M. J. (2012). The estimation and use of measurement uncertainty for a drug substance test procedure validated according to USP

Cite this article

APA

    APA : Javed, R., Ijaz, S., & Waqar, K. (2016). Development and Characterization of Bilayer Sustained Release Tablets of Tramadol HCl and Acetaminophen. Global Pharmaceutical Sciences Review, I(I), 6-16. https://doi.org/10.31703/gpsr.2016(I-I).02

CHICAGO

    CHICAGO : Javed, Rashid, Sana Ijaz, and Kainat Waqar. 2016. "Development and Characterization of Bilayer Sustained Release Tablets of Tramadol HCl and Acetaminophen." Global Pharmaceutical Sciences Review, I (I): 6-16 doi: 10.31703/gpsr.2016(I-I).02

HARVARD

    HARVARD : JAVED, R., IJAZ, S. & WAQAR, K. 2016. Development and Characterization of Bilayer Sustained Release Tablets of Tramadol HCl and Acetaminophen. Global Pharmaceutical Sciences Review, I, 6-16.

MHRA

    MHRA : Javed, Rashid, Sana Ijaz, and Kainat Waqar. 2016. "Development and Characterization of Bilayer Sustained Release Tablets of Tramadol HCl and Acetaminophen." Global Pharmaceutical Sciences Review, I: 6-16

MLA

    MLA : Javed, Rashid, Sana Ijaz, and Kainat Waqar. "Development and Characterization of Bilayer Sustained Release Tablets of Tramadol HCl and Acetaminophen." Global Pharmaceutical Sciences Review, I.I (2016): 6-16 Print.

OXFORD

    OXFORD : Javed, Rashid, Ijaz, Sana, and Waqar, Kainat (2016), "Development and Characterization of Bilayer Sustained Release Tablets of Tramadol HCl and Acetaminophen", Global Pharmaceutical Sciences Review, I (I), 6-16

TURABIAN

    TURABIAN : Javed, Rashid, Sana Ijaz, and Kainat Waqar. "Development and Characterization of Bilayer Sustained Release Tablets of Tramadol HCl and Acetaminophen." Global Pharmaceutical Sciences Review I, no. I (2016): 6-16. https://doi.org/10.31703/gpsr.2016(I-I).02